After a turbulent year that roiled the economy, and the health care sector more than most, the Democrats emerged with control of both the White House and Congress for the first time since 2014. Business leaders and in-house...more
2/17/2021
/ Abuse of Dominance ,
Antitrust Division ,
Antitrust Immunity ,
Antitrust Litigation ,
Antitrust Provisions ,
Biden Administration ,
Biosimilars ,
CREATE Act ,
Department of Justice (DOJ) ,
Discovery Costs ,
Enforcement ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Hatch-Waxman ,
Health Care Providers ,
Health Insurance ,
Hospital Mergers ,
Hospitals ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
McCarran-Ferguson Act ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physicians ,
Prescription Drugs ,
Presidential Appointments ,
Repeal ,
Research and Development ,
Reverse Payments ,
Risk Mitigation ,
Webinars
Now more than ever, in-house counsel are looking to demonstrate value and generate revenue for their businesses. They often neglect an obscure but profitable revenue stream: recoveries from antitrust class action settlements....more
Join us as Robins Kaplan attorneys Meegan Hollywood and William Reiss provide an introduction to the fundamentals of federal antitrust and competition law. The program will focus on the basic statutory framework of antitrust...more